Physician profile
David T Trice
NPI 1508806597
$1,316.09
in general payments reported to CMS, 2019-2025
22 companies · $20.43 in 2025
The $20.43 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $119 · 2021: $366 · 2022: $363 · 2023: $62.01 · 2024: $211 · 2025: $20.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $204.30 | 2022-2023 | Indigo System |
| Medtronic, INC. | $168.94 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Cardiva Medical, INC. | $145.15 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.07 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $82.22 | 2021-2022 | |
| Amgen INC. | $76.75 | 2019-2022 | |
| Pfizer INC. | $54.09 | 2024 | |
| Sanofi-Aventis U.S. LLC | $40.52 | 2024 | |
| Teleflex LLC | $40.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $35.10 | 2022-2023 | |
| Medtronic Vascular, INC. | $33.62 | 2019-2020 | |
| Shockwave Medical, INC | $26.58 | 2022 | |
| Abbott Laboratories | $20.52 | 2024 | Sensitherm Multi |
| Acutus Medical, INC. | $20.03 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $18.20 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.05 | 2019 | |
| Lantheus Medical Imaging, INC. | $17.58 | 2023 | Definity |
| Boston Scientific Corporation | $17.18 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $13.46 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $11.29 | 2020 | |
| Cardiovascular Systems INC. | $4.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Trice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.